Loading clinical trials...
Loading clinical trials...
A Triple-blinded, Randomized, Parallel-group Placebo-controlled Trial to Assess the Impact of Maternal Antenatal Melatonin Supplementation on Early Childhood Neurodevelopmental Outcomes in the Setting of Severe Preterm Fetal Growth Restriction
Conditions
Interventions
Placebo
Melatonin 10 MG
Locations
12
Australia
Royal Prince Alfred
Camperdown, New South Wales, Australia
John Hunter Hospital
Newcastle, New South Wales, Australia
Mater Misericordiae
South Brisbane, Queensland, Australia
Gold Coast University Hospital
Southport, Queensland, Australia
Women's and Children's Hospital
North Adelaide, South Australia, Australia
Monash Health
Clayton, Victoria, Australia
Start Date
May 29, 2019
Primary Completion Date
April 30, 2027
Completion Date
April 30, 2027
Last Updated
June 6, 2025
NCT06952777
NCT04720690
NCT05038462
NCT02583763
NCT04451109
NCT06215690
Lead Sponsor
Monash University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions